artificia

In this interview, David Dungay from UC Today is joined by Mark Bunnell, Chief Operating Officer from NUWAVE.

Together, they explore NUWAVE's stance on security and how they are providing a service to enable partners to safely adopt Microsoft Teams and deliver it to their customers in a safe manner. Discussion points include:

• How companies are now prioritising security when planning their modern workplace
• How NUWAVE has encompassed security across the product set
• Constellation and how partners can use the service to remain secure ongoing
• How is AI impacting the security landscape?

This episode follows S2 E43 in discussing the possible role of NASH cirrhosis clinical trials in the transition from biopsy as gold standard to a post-biopsy world. Terns Pharma CEO Sen Sundaram joins this conversation from the audience to ask whether the term "cirrhosis" is medically helpful or might warrant replacement with "end stage liver disease." After vigorous discussion on this point, Sen departs and Stephen Harrison leads the group through a review of four ongoing NASH cirrhosis trials. The discussion veers into the issue of which analytics methods designers are specifying and why. At one point, Naim Alkhouri, frequent guest and principal investigator on the Gilead combination agent trial before the session ends. His specific contribution: MRE was not included in the Gilead trial largely for cost reasons.

The most striking fact to emerge from this conversation relates to the "beyond the biopsy" question. MRE is emerging as a highly reliable NIT that appears to produce reliable results regardless of mode of action and is generating correlations and ratios to fibrosis level decreases and other key metrics, yet it is not included in the designs of any ongoing NASH cirrhosis trial. Stephen describes this as the "stovepiping" of data. Companies consider the data they need, not ways it can be aggregated with other trials to solve larger issues. This issue bears further exploration in later episodes.

Health2049 co-hosts Bisi Williams and Jason Helgerson look back at season one to discuss inspirational stories and innovative ideas in healthcare. With 19 podcast guests from diverse backgrounds, this season was jam packed with a variety of viewpoints that opened up new perspectives on the way forward into an industry ripe for disruption. What were the common themes? What surprised our co-hosts? What voices were missing? Find out as they reflect on the season and share their insights about the future of healthcare.

Connect with Health2049:

• Website:https://www.health2049.com

Timestamps: 

• Common themes in season one? [02:35]
• How artificial intelligence can give us the opportunity to live a better life. [05:05]
• An example of a highly efficient and respectful patient-centered experience. [06:05]
• What’s the future of wellness? [07:45]
• A future healthcare system that offers personalized medical plans. [07:45]
• What guests had differing points of view? [09:35]
• The future of healthcare payments. [10:17]
• A surprising perspective on paying for healthcare.[11:25]
• Healthcare payment alternatives. [12:24]
• What’s the point of new innovations if everyone doesn’t have access? [13:14]
• What perspectives surprised our podcast hosts? [14:07]
• We aren’t training medical students for the future. [15:20]
• Artificial intelligence can be more beneficial than in-person. [17:12]
• Compassion and community as tools for healing. [22:20]
• Profound personal experiences about empathy. [24:40]
• The diverse backgrounds of the podcast guests. [27:03]
• Medical providers don’t respect the patient’s time. [27:37]
• An empathic patient-provider point of view. [28:58]
• Innovative healthcare that demonstrates a value-based payment system. [30:50]
• What healthcare voices were missing from season one? [33:20]